Investing.com - Cosmos Pharmaceutical Corp reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Cosmos Pharmaceutical Corp announced earnings per share of ¥163.7 on revenue of ¥206.12B. Analysts polled by Investing.com anticipated EPS of ¥158.0 on revenue of ¥205.24B.
Cosmos Pharmaceutical Corp shares are down 14.83% from the beginning of the year and are trading at ¥14,420.0 , down-from-52-week-high.
Cosmos Pharmaceutical Corp follows other major Consumer Staples sector earnings this month
Cosmos Pharmaceutical Corp's report follows an earnings beat by Seven & i Holdings on Thursday, who reported EPS of ¥80.44 on revenue of ¥3,204.19B, compared to forecasts EPS of ¥73.54 on revenue of ¥3,246.17B.
Aeon had missed expectations on Wednesday, October 5, 2022 with second quarter EPS of ¥-1.61 on revenue of ¥2,283.96B, compared to forecast for EPS of ¥12.56 on revenue of ¥2,255.72B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar